Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting

A number of risk factors have been implicated in the development of chemotherapy-induced nausea/vomiting (CINV). Our aim was to develop a risk prediction model and identify patients at high risk for developing CINV before their chemotherapy treatment. A multisite, observational, prospective longitudinal design was used. Participants were 336 chemotherapy-naive cancer patients providing 791 assessments. They completed measures to assess potential...